An impurity was found in Pfizer’s heart and blood pressure medication Accupril that has led to a recall of several lots of the drug. The contaminant, known as a nitrosamine, can be carcinogenic at high levels and can increase a patient’s risk of developing cancer over time.
Patients are advised against stopping their medication at this time. Rather, those that are concerned that they may have pills from ...
continue reading...
Drug manufacturer Pfizer has moved to recall several lots of blood pressure pills over concerns that the medication may have been tainted with a carcinogenic contaminant. The affected medications include Accuretic, which is a tablet distributed by Pfizer itself, as well as a line of medications distributed by a second manufacturer known as Greenstone. The Greenstone lots include a pill that combines quinapril hydrochloride and hydrochlorothiazide ...
2020 has not been kind to Sanofi’s flagship heartburn medication Zantac. When reports first surfaced of contamination of the medication with a known carcinogen, attention immediately turned to the labs that made ranitidine, the active ingredient in Zantac. It wasn’t until researchers discovered that Zantac could be producing the carcinogen itself that calls began for a recall of the drug. The mechanism that could lead to such an occurrence, however, has ...
As the number of lawsuits filed over NDMA contaminated Zantac continues to grow, over 140 such suits have been sent to a federal judge to be heard as a multidistrict litigation. The MDL will be the first for U.S. District Judge Robin Rosenberg who serves as a judge for the Southern District of Florida. In selecting Judge Rosenberg, the Judicial Panel on Multidistrict Litigation called her “an ...
New concerns are emerging over the presence of a known carcinogen in the compound used to make heartburn medication Zantac. Things have taken an interesting twist however, as researchers explore the possibility that the source of the contamination may be the Zantac itself.
The issue of NDMA contamination in Zantac and other drugs based on its main ingredient first came to light last year. That was when ...
continue reading...
Plaintiffs in valsartan-based drug lawsuits filed over possible carcinogenic contamination may have to make room for additional consumers as lawyers push for the inclusion of two other blood pressure medications, losartan and irbesartan. Batches of the drugs, in addition to valsartan, have been found to be tainted with NDMA, or nitrosodimethylamine. NDMA is a known human carcinogen and has been linked to the development of certain ...
